[Dihydrofolate reductase and thymidine kinase in the bone marrow under the influence of folic acid antagonists].
D000328:Adult; D000686:Amyloidosis / Q000097:blood; D001853:Bone Marrow / Q000201:enzymology*; D001854:Bone Marrow Cells; D002908:Chronic Disease; D004796:Clinical Enzyme Tests; D004247:DNA / Q000096:biosynthesis; D004920:Erythropoiesis; D005260:Female; D005493:Folic Acid Antagonists / Q000494:pharmacology*; D005921:Glomerulonephritis / Q000097:blood; D006801:Humans; D066298:In Vitro Techniques; D008180:Lupus Erythematosus, Systemic / Q000097:blood; D008297:Male; D008727:Methotrexate / Q000506:poisoning; D013405:Suicide; D013762:Tetrahydrofolate Dehydrogenase / Q000378:metabolism*; D013937:Thymidine Kinase / Q000378:metabolism*
D005493:Folic Acid Antagonists; D004247:DNA; D013762:Tetrahydrofolate Dehydrogenase; D013937:Thymidine Kinase; D008727:Methotrexate
Dihydrofolat-Reductase und Thymidin-Kinase im Knochenmark unter der Einwirkung von Folsäureantagonisten.